BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BOPA - ECPv6.17.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.bopa.org.uk
X-WR-CALDESC:Events for BOPA
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250620
DTEND;VALUE=DATE:20250622
DTSTAMP:20250514T084824Z
CREATED:20250514T084824Z
LAST-MODIFIED:20250514T084824Z
UID:34641-1750377600-1750550399@www.bopa.org.uk
SUMMARY:ESC Cardio-Oncology 2025
DESCRIPTION:ESC Cardio-Oncology 2025 marks an exciting new chapter for our community. ​ \nOrganised by the ESC Council of Cardio-Oncology who inspired the launch of the first ESC Guidelines and ESC Core Curriculum within this discipline\, we are thrilled to announce our inaugural meeting\, created to establish a dedicated platform for this rapidly advancing specialty.​ \nThe comprehensive Scientific Programme will offer a 360° view of the cardio-oncology landscape\, covering everything from cutting-edge research to real-world clinical cases. With tailored tracks for both general cardiologists and advanced specialists\, this congress ensures that all participants – regardless of their experience – will gain actionable insights directly applicable to their clinical practice. ​\n​\nReflecting its commitment to interdisciplinary connections\, ESC Cardio-Oncology 2025 will provide extensive networking opportunities for specialists in cardiology\, oncology\, haematology\, radiotherapy\, and related fields\, fostering new partnerships and collaborations that will drive progress in the discipline.​\n​\nTogether\, let’s turn a new page in cardio-oncology and commit to improving outcomes for patients worldwide. \n\nBook the conference days in your agenda\nRegister early for the best savings\nBrowse the Scientific Programme (regularly updated)
URL:https://www.bopa.org.uk/event/esc-cardio-oncology-2025/
LOCATION:Florence\, Florence\, Italy
ATTACH;FMTTYPE=image/jpeg:https://www.bopa.org.uk/wp-content/uploads/2025/05/ESC-Cardio-Oncology-Visual_escardio-PosterEI.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250620T120000
DTEND;TZID=Europe/London:20250620T130000
DTSTAMP:20250616T201323Z
CREATED:20250612T170924Z
LAST-MODIFIED:20250616T201323Z
UID:33444-1750420800-1750424400@www.bopa.org.uk
SUMMARY:BOPA E&T Webinar: Harnessing AI in Oncology Pharmacy Practice – Focus on Administrative Efficiency
DESCRIPTION:Friday 20th June 2025 at 12:00 BST\n  \nClick HERE to register\n  \nThe BOPA Education and Training Subcommittee would like to invite you to the E&T Webinar: Harnessing AI in Oncology Pharmacy Practice – Focus on Administrative Efficiency by Bastiaan Buijtenhuijs and Pinkie Chambers\, Co-Chairs of the BOPA Artificial Intelligence (AI) Specialist Advisory Group\, and Phil Barron. \nSpeakers’ Biography: \n \nBastiaan works for iQ HealthTech as the head of product and the product owner for iQemo. iQemo is a best of breed SACT prescribing system and is widely used in the UK and internationally. As the product owner Bastiaan is responsible for being the interface between the customers – their requirements and the development team to allow new functionality to be effectively developed. He has undertaken the NHS Digital academy and was part of Cohort 3. He has recently completed his MSc as part of the NHS Digital academy and written his dissertation on how to successfully implement an advanced Ai driven Clinical decision support system in the Oncology Pharmacy setting. \n \nPinkie is a clinical academic at University College London (UCL) and University College NHS Foundation Trust. Her research activities are all around improving the delivery of systemic anticancer treatments and has experience of using large datasets and prognostic modelling techniques. She has held various roles within cancer including developing new clinic pharmacy services at UCLH and Lead Pharmacist for London Cancer. She the current co-chair of the UK Chemotherapy board \, joint audit\, and research lead for BOPA and chair of The Chemotherapy Expert Reference group at the NCL cancer alliance as well as a member of the Heath Foundation Q Community. \n \n\nPhil is Chief Pharmacy Information Officer at The Clatterbridge Cancer Centre NHS Foundation Trust and is also a digital clinical safety officer at the trust. He leads a team of digital pharmacists and pharmacy technicians\, delivering projects including Omnicell\, System C\, and the pharmacy workstream of the Trust’s EPR optimisation programme. Phil is an enthusiastic user of AI in practice and is exploring the use of tools like Microsoft Copilot in pharmacy. He is a member of the BOPA AI Scientific Advisory Group.
URL:https://www.bopa.org.uk/event/bopa-et-webinar-harnessing-ai-in-oncology-pharmacy-practice-focus-on-administrative-efficiency/
LOCATION:Virtual – Online
CATEGORIES:Education and Training,Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.bopa.org.uk/wp-content/uploads/2023/05/BOPA-Webinar-Final-pride-high-res_Edu-Black-10-scaled.jpg
ORGANIZER;CN="British Oncology Pharmacy Association (BOPA)":MAILTO:contact@bopa.org.uk
END:VEVENT
END:VCALENDAR